
The acquisition of Mountain View, California based Reliant Technologies by Thermage Inc. was recently completed. The deal was reportedly valued at approximately $66.2 million in stock and cash. Reliant has become a fixture in the cosmetic surgery market, largely because of the success of Fraxel, its brand of fractional laser technology treatment.
The acquisition required $23 million in stock shares, $25 million cash and must assume $7 million of Reliant’s debt. Shares of Reliant stock have dropped since the deal was publicized in July.
With the effectiveness of Fraxel laser technology, Reliant has been a highly profitable company. Fraxel treatments stimulate collagen growth and resurface skin by penetrating the outer dermis with ‘fractional’ microscopic laser columns. The patient’s natural, bodily healing process then promotes skin rejuvenation and collagen growth.
Thermage is known for marketing a unique, non-invasive skin treatment that uses radiofrequency technology to heat and subsequently tighten skin. The treatment is also said to improve superficial skin characteristics like texture and tone.
In Seattle, Dr. Stacy is one of the few cosmetic practices offering both Fraxel Repair and Thermage. Dr. Stacy has been a physician trainer for Thermage and provides highly effective combination treatments customized to each individual’s needs.